Targeting the angiotensin system in posttransplant airway obliteration: The antifibrotic effect of angiotensin converting enzyme inhibition

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 1, 2000, Pages 310-315

  Maclean, Alexandra A ^a   Liu, Mingyao ^a   Fischer, Stefan ^a   Suga, Michihura ^a   Keshavjee, Shaf ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; DRUG EFFICACY; LUNG INJURY; LUNG TRANSPLANTATION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; TRACHEA;

EID: 0033926060     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.1.9910114     Document Type: Article

References (33)

1. 1. Sundaresan, S. 1998. Bronchiolitis ohliterans. Semin. Thorac. Cardiovasc. Surg. 10:221-226.
2. 2. Hosenpud, J. D., L. E. Bennett, B. M. Keck, B. Fiol, and R. J. Novick. 1997. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report-1997. J. Heart Lung Transplant. 16:691-712.
3. 3. Boehler, A., D. Chamberlain, S. Kesten, A. S. Slutsky, M. Liu, and S. Keshavjee. 1997. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 64:311-317.
4. 4. Koskinen, P. K., E. A. Kallio, C. A. Bruggeman, and K. B. Lemström. 1997. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am. J. Respir. Crit. Care Med. 155:2078-2088.
5. 5. Hertz, M. I., C. A. Henke, R. E. Nakhleh, K. R. Harmon, W. A. Marinelli, J. M. Fox, S. H. Kubo, S. J. Shumway, R. M. Bolman 3d, and P. B. Bitterman. 1992. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc. Natl Acad. Sci. U.S.A. 89:10385-10389.
6. 6. Yousem, S. A., L. Ray, I. L. Paradis, J. A. Duaber, and B. P. Griffith. 1990. Potential role of dendritic cells in bronchiolitis obliterans in human heart-lung transplantation. Ann. Thorac. Surg. 49:424-428.
7. 7. Mulrow, P. J. 1999. Angiotensin II and aldosterone regulation. Regul. Pept. 80:27-32.
8. 8. Ardaillou, R., and J.-B. Michel. 1999. The relative roles of circulating and tissue renin-angiotensin systems. Nephrol. Dial. Transplant. 14:283-286.
9. 9. Hisada, Y., T. Sugaya, M. Yamanouchi, H. Uchida, H. Fujimura, H. Sakurai, A. Fukamizu, and K. Murakami. 1999. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J. Clin. Invest. 103:627-635.
10. 10. Sun, Y., and K. T. Weber. 1996. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J. Mol. Cell. Cardiol. 28:851-858.
11. 11. Weber, K. T. 1997. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin. Nephrol. 17:467-491.
12. 12. Ratajska, A., S. E. Campbell, J. P. Cleutjens, and K. T. Weber. 1994. Angiotensin II and structural remodeling of coronary vessels in rats. J. Lab. Clin. Med. 124:408-415.
13. 13. Katwa, L. C., Y. Sun, S. E. Campbell, S. C. Tyagi, A. K. Dhalla, J. C. Kandala, and K. T. Weber. 1998. Pouch tissue and angiotensin peptide generation. J. Mol. Cell. Cardiol. 30:1401-1413.
14. 14. Ward, W. F., A. Molteni, C. H. Ts'ao, Y. T. Kim, and J. M. Hinz. 1992. Radiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme. Int. J. Radiat. Oncol. Biol. Phvs. 22:623-625.
15. 15. Kobayashi, J., S. E. Crawford, C. L. Backer, V. R. Zales, H. Takami, C. Hsueh, L. Huang, and C. Mavroudis. 1993. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. Circulation 88(5, Pt. 2):II286-290.
16. 16. Crawford, S. E., L. Huang, W. Hsueh, H. Takami, F. Gonzalez-Crussi, C. L. Backer, Y. Mu, H. Liu, and C. Mavroudis. 1999. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. J. Heart Lung Transplant. 18:470-477.
17. 17. Amuchastegui, S. C., N. Azzollini, M. Mister, A. Pezzotta, N. Perico, and G. Remuzzi. 1998. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J. Am. Soc. Nephrol. 9:1948-1955.
18. 18. Reichenspurner, H., V. Soni, M. Nitschke, G. J. Berry, T. Brazelton, R. Shorthouse, X. Huang, J. Boname, R. Girgis, B. A. Raitz, E. Mocarski, G. Sandford, and R. E. Morris. 1998. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. J. Heart Lung Transplant. 17:439-451.
19. 19. Zheng, L., C. Ward, G. I. Snell, B. E. Orsida, X. Li, J. W. Wilson, T. J. Williams, and E. H. Walters. 1997. Scar collagen deposition in the airways of allografts of lung transplant recipients. Am. J. Respir. Crit. Care Med. 155:2072-2077.
20. 20. Song, L., D. Wang, X. Cui, Z. Shi, and H. Yang. 1998. Kinetic alterations of angiotensin-II and nitric oxide in radiation pulmonary fibrosis. J. Environ. Pathol. Toxicol. Oncol. 17:141-150.
21. 21. Baudin, B., M. Berard, J. L. Carrier, Y. Legrand, and L. Drouet, 1997. Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells. Endothelium 5:73-84.
22. 22. Kowala, M. C., M. Valentine, R. Reece, S. Beyer, N. Goller, S. Durham, and G. Aberg. 1998. Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril. J. Cardiovasc. Pharmacol. 32:29-38.
23. 23. Roisman, G. L., C. J. Danel, J. G. Lacronique, F. Alhene-Gelas, and D. J. Dusser, 1999. Decreased expression of angiotensin-converting enzyme in the airway eptihelium of asthmatic subjects is associated with eosinophil inflammation. J. Allergy Clin. Immunol. 104:402-410.
24. 24. Linz, W., and B. A. Scholkens. 1992. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibition. J. Cardiovasc. Pharmacol. 20:S83-S90.
25. 25. Ward, W. F., A. Molteni, C. H. Ts'ao, and J. M. Hinz. 1990. Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int. J. Radiat. Oncol. Biol. Phys. 19:1405-1409.
26. 26. Owen, C. A., and E. J. Campbell. 1998. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J. Immunol. 160:1436-1443.
27. 27. Balcells, E., Q. C. Meng, W. H. Johnson, Jr., S. Oparil, and L.J. Dell'Italia. 1997. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am. J. Physiol. 273:H1769-H1774.
28. 28. Voors, A. A., Y. M. Pinto, H. Buikema, H. Urata, M. Oosterga, G. Rooks, J. G. Grandjean, D. Ganten, and W. H. van Gilst. 1998. Dual pathway for angiotensin II formation in human internal mammary arteries. Br. J. Pharmacol. 125:1028-1032.
29. 29. Peters, H., W. A. Border, and N. A. Noble. 1998. Targeting TGF-β overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int. 54:1570-1580.
30. 30. Lijnen, P., and V. Petrov. 1999. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J. Mol. Cell. Cardiol. 31:949-970.
31. 31. Brazelton, T. R. 1997. Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection. Transplant. Proc. 29:2614.
32. 32. Qin, L., Y. Ding, and J. S. Bromberg, 1996. Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum. Gene Ther. 7:1981-1988.
33. 33. El-Gamel, A., M. Awad, E. Sim, P. Hasleton, N. Yonan, J. Egan, A. Deiraniya, and I.V. Hutchinson. 1998. Transforming growth factor-beta1 and lung allograft fibrosis. Eur. J. Cardiothorac. Surg. 13:424-430.